Business
Ventripoint Makes Application to Amend Warrants
(TheNewswire) Toronto, Ontario, April 3, 2025 – TheNewswire - Ventripoin...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Makes Application to Amend Warrants\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Toronto, Ontario, April 3,\n2025\n \n\n –\n \n\n TheNewswire -\n \n\n Ventripoint Diagnostics Ltd.\n \n\n (\"\n \n\n Ventripoint\n \n\n \" or the \"\n \n\n Company\n \n\n \"),\n(TSXV:VPT; OTC:VPTDF)\n \n\n announces that it has\nmade an application to the TSX Venture Exchange (the “\n \n\n TSXV\n \n\n ”) to extend\nthe expiry date of a total of\n \n\n 2,845,771 common\nshare purchase warrants (the “\n \n\n Warrants\n \n\n ”) exercisable at $0.30. The\nWarrants were originally issued by the Company in connection with a\nprivate placement financing\n \n\n made to\npurchasers’ resident in Canada, except Quebec, pursuant to the\nlisted issuer financing exemption under Part 5A of National Instrument\n45-106\n \n\n Prospectus Exempt\nDistributions,\n \n\n which closed in two tranches on\nOctober 17, 2024 and November 12, 2024. (see press releases on August\n29, 2024, September 17, 2024, October 15, 2024 and November 14, 2024).\n \n\n\n\n An aggregate of 2,351,730 Warrants issued October 17,\n2024 and expiring April 17, 2025 and an aggregate of 494,041 Warrants\nissued November 12, 2024 and expiring May 12, 2024 will now expire on\nApril 17, 2026.\n \n\n\n\n The Warrants to be amended do not include warrants\nissued to finders. All other provisions of the Warrants will remain\nthe same and holders will not receive an amended Warrant certificate.\n \n\n\n\n The Warrant extension is subject to final acceptance by\nTSXV Exchange.\n \n\n\n\n About Ventripoint Diagnostics\nLtd.\n \n\n\n\n Ventripoint\n \n\n has become an\nindustry leader in the application of AI (Artificial Intelligence) to\nechocardiography. Ventripoint's VMS+ products are powered by its\nproprietary knowledge-based reconstruction technology, which is the\nresult of a decade of development and provides accurate volumetric\ncardiac measurements equivalent to MRI. This affordable, gold-standard\nalternative allows cardiologists greater confidence in the management\nof their patients. Providing better care to patients serves as a\nspringboard and basic standard for all of Ventripoint's products that\nguide our future developments. In addition, VMS+ is versatile and can\nbe used w...